These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26694594)

  • 1. Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.
    Coloma PM; de Ridder M; Bezemer I; Herings RM; Gini R; Pecchioli S; Scotti L; Rijnbeek P; Mosseveld M; van der Lei J; Trifirò G; Sturkenboom M;
    Osteoporos Int; 2016 May; 27(5):1857-67. PubMed ID: 26694594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study.
    Herrera L; Leal I; Lapi F; Schuemie M; Arcoraci V; Cipriani F; Sessa E; Vaccheri A; Piccinni C; Staniscia T; Vestri A; Di Bari M; Corrao G; Zambon A; Gregori D; Carle F; Sturkenboom M; Mazzaglia G; Trifiro G
    Osteoporos Int; 2015 May; 26(5):1499-506. PubMed ID: 25752621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study.
    van den Boogaard CH; Breekveldt-Postma NS; Borggreve SE; Goettsch WG; Herings RM
    Curr Med Res Opin; 2006 Sep; 22(9):1757-64. PubMed ID: 16968579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea.
    Jung SY; Sohn HS; Park EJ; Suh HS; Park JW; Kwon JW
    PLoS One; 2016; 11(3):e0150531. PubMed ID: 26937968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Large National Cohort Study of the Association between Bisphosphonates and Osteonecrosis of the Jaw in Patients with Osteoporosis: A Nested Case-control Study.
    Kwon JW; Park EJ; Jung SY; Sohn HS; Ryu H; Suh HS
    J Dent Res; 2015 Sep; 94(9 Suppl):212S-9S. PubMed ID: 26001708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.
    Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM
    Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral bisphosphonates and risk of ischemic stroke: a case-control study.
    Christensen S; Mehnert F; Chapurlat RD; Baron JA; Sørensen HT
    Osteoporos Int; 2011 Jun; 22(6):1773-9. PubMed ID: 20945149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.
    Green J; Czanner G; Reeves G; Watson J; Wise L; Beral V
    BMJ; 2010 Sep; 341():c4444. PubMed ID: 20813820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study.
    Spoendlin J; Meier C; Jick SS; Meier CR
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1116-1123. PubMed ID: 27297005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of oral bisphosphonates and risk of venous thromboembolism: a population-based case-control study.
    Lamberg AL; Horvath-Puho E; Christensen S; Sørensen HT
    Osteoporos Int; 2010 Nov; 21(11):1911-7. PubMed ID: 19997902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance of oral bisphosphonates: adverse effects manifesting in the soft tissue of the oral cavity.
    Kharazmi M; Persson U; Warfvinge G
    J Oral Maxillofac Surg; 2012 Dec; 70(12):2793-7. PubMed ID: 22609135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
    Khalid S; Calderon-Larranaga S; Sami A; Hawley S; Judge A; Arden N; Van Staa TP; Cooper C; Abrahamsen B; Javaid MK; Prieto-Alhambra D
    Osteoporos Int; 2022 Jul; 33(7):1579-1589. PubMed ID: 35138412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence with bisphosphonate therapy including treatment courses with multiple sequential bisphosphonates in the real world.
    Ideguchi H; Ohno S; Hattori H; Ishigatsubo Y
    Osteoporos Int; 2007 Oct; 18(10):1421-7. PubMed ID: 17577595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance.
    Ali MS; Berencsi K; Marinier K; Deltour N; Perez-Guthann S; Pedersen L; Rijnbeek P; Lapi F; Simonetti M; Reyes C; Van der Lei J; Sturkenboom M; Prieto-Alhambra D
    Osteoporos Int; 2020 Dec; 31(12):2425-2438. PubMed ID: 32757044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of persistence in osteoporosis therapy with oral bisphosphonates in Italy: the TOBI study.
    Gonnelli S; Caffarelli C; Letizia Mauro G; Di Munno O; Malavolta N; Migliaccio S; Nuti R
    Aging Clin Exp Res; 2019 Nov; 31(11):1541-1547. PubMed ID: 31030419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.
    Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS
    Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH; Seal B; Tangirala M; Jeffcoat MK; Watts NB; Hay JW
    Gen Dent; 2010; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of bisphosphonates in osteoporosis.
    Watts NB; Diab DL
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saving bones without risking brain-bisphosphonates and risk of stroke: matched case-control study.
    Asghar ZB; Godoy Caballero A; Pathirannehelage S; Williams J; McKay S; Grassby P; de Lusignan S; Niroshan Siriwardena A
    Osteoporos Int; 2019 Sep; 30(9):1845-1854. PubMed ID: 31214750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.